Page last updated: 2024-09-04

bazedoxifene and Hereditary Hemorrhagic Telangiectasia

bazedoxifene has been researched along with Hereditary Hemorrhagic Telangiectasia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albiñana, V; Bernabéu, C; Botella, LM; Ojeda-Fernandez, L; Parra, JA; Recio, L; Zarrabeitia, R	1

Other Studies

1 other study(ies) available for bazedoxifene and Hereditary Hemorrhagic Telangiectasia

Article	Year
Bazedoxifene, a new orphan drug for the treatment of bleeding in hereditary haemorrhagic telangiectasia. Thrombosis and haemostasis, 2016, 06-02, Volume: 115, Issue:6 Topics: Activin Receptors, Type II; Aged; Cells, Cultured; Endoglin; Endothelial Cells; Female; Hemorrhage; Humans; Indoles; Middle Aged; Neovascularization, Physiologic; Orphan Drug Production; Pilot Projects; RNA, Messenger; Selective Estrogen Receptor Modulators; Telangiectasia, Hereditary Hemorrhagic; Vascular Endothelial Growth Factor A; Wound Healing	2016

Article

Year

Bazedoxifene, a new orphan drug for the treatment of bleeding in hereditary haemorrhagic telangiectasia.

Thrombosis and haemostasis, 2016, 06-02, Volume: 115, Issue:6

Topics: Activin Receptors, Type II; Aged; Cells, Cultured; Endoglin; Endothelial Cells; Female; Hemorrhage; Humans; Indoles; Middle Aged; Neovascularization, Physiologic; Orphan Drug Production; Pilot Projects; RNA, Messenger; Selective Estrogen Receptor Modulators; Telangiectasia, Hereditary Hemorrhagic; Vascular Endothelial Growth Factor A; Wound Healing

2016